AAS
ANIP icon

Ameritas Advisory Services’s ANI Pharmaceuticals ANIP Stock Holding History

Ameritas Advisory Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-41
Closed -$1.63K – 632
2023
Q1 		$1.63K Buy
+41
New +$1.73K ﹤0.01% 2453

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Ameritas Advisory Services's ANIP Position: Q2 2023 in Review

Ameritas Advisory Services sold out of ANI Pharmaceuticals (ANIP) in Q2 2023, closing a stake of 41 shares — an estimated $1.63K sold.

Ameritas Advisory Services first reported a position in ANIP in Q1 2023 and held it in 1 quarter. The position peaked at $1.63K in Q1 2023. 171 funds tracked by Wall St. Rank hold ANIP as of Q2 2023.

  • Ameritas Advisory Services reported no remaining ANI Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Ameritas Advisory Services sold 41 ANI Pharmaceuticals shares in Q2 2023, an estimated $1.63K.
  • Ameritas Advisory Services first reported a position in ANI Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Ameritas Advisory Services's ANI Pharmaceuticals position peaked at $1.63K in Q1 2023.
  • 171 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2023.

Based on Ameritas Advisory Services's 13F filing for Q2 2023, filed 25 Jul 2023.